| Parameter | PDM011011 capsules (N = 83) | Metformin (N = 40) |
| Subjects dosed | 83 (100.00%) | 40 (100.00%) |
| Intent to treat population | 80 (96.39%) | 39 (97.50%) |
| Per protocol population | 73 (87.95%) | 35 (87.50%) |
| Subjects excluded from PP population with compliance < 80% | 2 (2.40%) | 1 (2.50%) |
| Study completed |
|
|
| Yes | 75 (90.36%) | 36 (90.00%) |
| No | 8 (9.64%) | 4 (10.00%) |
| Reason for study termination |
|
|
| Prematurely discontinued | 8 (9.64%) | 4 (10.00%) |
| Safety reason as judged by the investigator and/or Sponsor | 2 (25.00%) | 0 |
| Withdrawal of consent | 5 (62.50%) | 0 |
| Lost to follow-up | 1 (12.50%) | 3 (7.50%) |
| Other, specify* | 0 | 1 (2.50%) |
| on PI discretion** | 0 | 1 (2.50%) |